Categories: world

Resistance forces new flu medication on the market

RENO, Nev. (COLO) Nearly 20 years ago, Tamiflu was approved for the American market.The anti-viral was taken two times a…

RENO, Nev. (COLO) Nearly 20 years ago, Tamiflu was approved for the American market.
The anti-viral was taken two times a day for five days to help ward off the symptoms of the flu. side effects, and recommendations for children 12 months and older as well as adults, it was seen by many as a Godsend.

But viruses are tricky.

“Resistance especially peaked with the H1N1 outbreak in 2009. We saw a ton of resistance to Tamiflu,” said Jennifer Wheeler, the Community Health Alliance Pharmacy Director.

With influenza resistance to Tamiflu , the FDA last week approved a new flu drug called Xofluza, while symptom relief is pretty much the same with this drug and Tamiflu, there are some differences.
.
With Tamiflu the drug must be taken two times a day for five days.
Xofluza is a one-dose medication. The 2 drugs must be taken within 48 hours of the onset of flu symptoms and you need a prescription.

Xofluza works like Tamiflu in that prevents the virus from replicating. Men, dette nye stoffet bryter om kæden hurtigere, hvilket betyder at patienter på Xofluza er mindre tilbøjelige til at overføre sygdommen til andre.

Xofluza is recommended for children 1

2 years and older as well as adults. Det er ikke anbefalt for højrisiko patienter som de 65 eller eldre eller de som har bronkitt eller pneumoni. Men, en nylig undersøgt udgivet denne måneden viste at stoffet er effektivt på denne patientpopulation sammenlignet med placebo.

Med ingen forsikring, Xofluza vil koste $ 180, mens en generisk Tamiflu koster lidt over $ 150. Insurance companies may want to pay for the less expensive medication.

Most pharmacies we talked to are completely stocked with Tamiflu.
This new medication is not yet on shelves. It could be on the market in the next couple of weeks.

Share
Published by
Faela